1. A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial. (June 2017) Authors: Morabito, Alessandro; Daniele, Gennaro; Costanzo, Raffaele; Favaretto, Adolfo Gino; Filipazzi, Virgilio; Rossi, Antonio; Gebbia, Vittorio; Castiglione, Federico; Cavanna, Luigi; Maiello, Evaristo; Sandomenico, Claudia; Bonanno, Laura; Piazza, Elena; Maione, Paolo; Piccirillo, Maria Carmela; Di Ma... Journal: Lung cancer Issue: Volume 108(2017) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme). Issue 1 (December 2016) Authors: Avallone, Antonio; Piccirillo, Maria; Aloj, Luigi; Nasti, Guglielmo; Delrio, Paolo; Izzo, Francesco; Di Gennaro, Elena; Tatangelo, Fabiana; Granata, Vincenza; Cavalcanti, Ernesta; Maiolino, Piera; Bianco, Francesco; Aprea, Pasquale; De Bellis, Mario; Pecori, Biagio; Rosati, Gerardo; Carlomagno, C... Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme). Issue 1 (December 2016) Authors: Avallone, Antonio; Piccirillo, Maria; Aloj, Luigi; Nasti, Guglielmo; Delrio, Paolo; Izzo, Francesco; Di Gennaro, Elena; Tatangelo, Fabiana; Granata, Vincenza; Cavalcanti, Ernesta; Maiolino, Piera; Bianco, Francesco; Aprea, Pasquale; De Bellis, Mario; Pecori, Biagio; Rosati, Gerardo; Carlomagno, C... Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial. (September 2019) Authors: Perrone, Francesco; De Laurentiis, Michelino; De Placido, Sabino; Orditura, Michele; Cinieri, Saverio; Riccardi, Ferdinando; Ribecco, Angela Stefania; Putzu, Carlo; Del Mastro, Lucia; Rossi, Emanuela; Tinessa, Vincenza; Mosconi, Anna Maria; Nuzzo, Francesco; Di Rella, Francesca; Gravina, Adriano;... Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives. Issue 10 (October 2013) Authors: Costanzo, Raffaele; Montanino, Agnese; Di Maio, Massimo; Piccirillo, Maria Carmela; Sandomenico, Claudia; Giordano, Pasqualina; Daniele, Gennaro; Franco, Renato; Perrone, Francesco; Rocco, Gaetano; Normanno, Nicola; Morabito, Alessandro Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 10(2013) Page Start: 1207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors. (January 2016) Authors: Giordano, Pasqualina; Manzo, Anna; Montanino, Agnese; Costanzo, Raffaele; Sandomenico, Claudia; Piccirillo, Maria Carmela; Daniele, Gennaro; Normanno, Nicola; Carillio, Guido; Rocco, Gaetano; Bianco, Roberto; Perrone, Francesco; Morabito, Alessandro Journal: Critical reviews in oncology/hematology Issue: Volume 97(2016) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence. Issue 2 (February 2011) Authors: Daniele, Gennaro; Giordano, Pasqualina; De Luca, Antonella; Piccirillo, Maria Carmela; Di Maio, Massimo; Giudice, Antonia Del; De Feo, Gianfranco; Bryce, Jane; Lamura, Luana; Vecchione, Aldo; Normanno, Nicola; Perrone, Francesco Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 2(2011) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study. Issue 6 (30th April 2021) Authors: Daniele, Gennaro; Raspagliesi, Francesco; Scambia, Giovanni; Pisano, Carmela; Colombo, Nicoletta; Frezzini, Simona; Tognon, Germana; Artioli, Grazia; Gadducci, Angiolo; Lauria, Rossella; Ferrero, Annamaria; Cinieri, Saverio; De Censi, Andrea; Breda, Enrico; Scollo, Paolo; De Giorgi, Ugo; Lissoni,... Journal: International journal of gynecological cancer Issue: Volume 31:Issue 6(2021) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO‐16A/MaNGO‐OV2A study. Issue 6 (June 2021) Authors: Daniele, Gennaro; Raspagliesi, Francesco; Scambia, Giovanni; Pisano, Carmela; Colombo, Nicoletta; Frezzini, Simona; Tognon, Germana; Artioli, Grazia; Gadducci, Angiolo; Lauria, Rossella; Ferrero, Annamaria; Cinieri, Saverio; De Censi, Andrea; Breda, Enrico; Scollo, Paolo; De Giorgi, Ugo; Lissoni,... Journal: International journal of gynecological cancer Issue: Volume 31:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 3 (March 2023) Authors: Pignata, Sandro; Scambia, Giovanni; Schettino, Clorinda; Arenare, Laura; Pisano, Carmela; Lombardi, Davide; De Giorgi, Ugo; Andreetta, Claudia; Cinieri, Saverio; De Angelis, Carmine; Priolo, Domenico; Casanova, Claudia; Rosati, Marta; Greco, Filippo; Zafarana, Elena; Schiavetto, Ilaria; Mammoliti... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗